Nautilus Biotechnology, Inc. NAUT
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 6.74% | 13.95% | 16.86% | 16.64% | 10.53% |
| Total Depreciation and Amortization | -13.23% | -8.30% | -2.40% | 0.43% | 1.94% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -30.37% | -42.06% | -48.68% | -49.10% | -25.49% |
| Change in Net Operating Assets | -26.98% | -12.74% | 8.01% | 34.35% | 23.01% |
| Cash from Operations | 0.28% | 8.18% | 12.24% | 14.29% | 10.40% |
| Capital Expenditure | -29.60% | 30.45% | 36.10% | 55.69% | 10.26% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -45.46% | -55.83% | -52.15% | -47.20% | 863.78% |
| Cash from Investing | -47.61% | -56.76% | -52.77% | -46.83% | 700.39% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 166.91% | 109.24% | 41.88% | -81.29% | -42.22% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 166.91% | 109.24% | 41.88% | -81.29% | -42.22% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -169.49% | -322.43% | -347.86% | -284.97% | 127.93% |